Terminated PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT00938457

Stereotactic Radiation Therapy in Treating Patients With Liver Metastases

A Phase I/II Dose-Finding Study of Single-Fraction Stereotactic Body Radiotherapy (SF-SBRT) for the Treatment of Liver Metastases

Sponsor: Mayo Clinic

Conditions Unspecified Adult Solid Tumor

Interventions cone-beam computed tomography implanted fiducial-based imaging stereotactic radiation therapy

Updated 8 times since 2017 Last updated: Apr 19, 2016 Started: Jul 31, 2009 Primary completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

poor accrual

Other terminated trials from Mayo Clinic

See all terminations from Mayo Clinic

This PHASE1/PHASE2 trial investigates Unspecified Adult Solid Tumor and is currently terminated or withdrawn. Mayo Clinic leads this study, which shows 8 recorded versions since 2009 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2023 — Jul 2024 [monthly]

Terminated PHASE1_PHASE2
Dec 2022 — Jan 2023 [monthly]

Terminated PHASE1_PHASE2
Jan 2021 — Dec 2022 [monthly]

Terminated PHASE1_PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1_PHASE2
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE1_PHASE2

First recorded

Jul 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mayo Clinic

Data source: Mayo Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rochester, United States